Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.06 USD | +2.38% | +1.25% | -2.55% |
Business Summary
Number of employees: 184
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Metzger
CEO | Chief Executive Officer | 53 | 15-05-04 |
Peter Ordentlich
FOU | Founder | 55 | 05-10-10 |
Neil Gallagher
PSD | President | 60 | 23-04-09 |
Keith Goldan
DFI | Director of Finance/CFO | 52 | 22-06-12 |
Chief Tech/Sci/R&D Officer | 52 | - | |
Briggs Morrison
CTO | Chief Tech/Sci/R&D Officer | 65 | 15-06-14 |
Sharon P. Klahre
IRC | Investor Relations Contact | - | 22-06-12 |
Anjali Ganguli
PRN | Corporate Officer/Principal | 48 | 15-04-30 |
Kevin McManus
HRO | Human Resources Officer | - | 23-04-30 |
Luke Albrecht
LAW | General Counsel | 45 | 16-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Keith Katkin
BRD | Director/Board Member | 52 | 17-03-28 |
Dennis Podlesak
CHM | Chairman | 66 | 08-11-30 |
Pierre Legault
BRD | Director/Board Member | 63 | 17-01-03 |
William Meury
BRD | Director/Board Member | 56 | 18-09-24 |
Briggs Morrison
CTO | Chief Tech/Sci/R&D Officer | 65 | 15-06-14 |
Martin Huber
BRD | Director/Board Member | 64 | 21-09-14 |
Michael Metzger
CEO | Chief Executive Officer | 53 | 15-05-04 |
Jennifer Jarrett
BRD | Director/Board Member | 53 | 18-09-24 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 84,979,686 | 83,411,029 ( 98.15 %) | 0 | 98.15 % |
Company contact information
Syndax Pharmaceuticals, Inc.
35 Gatehouse Drive Building D
02451, Waltham
+781 419 1400
http://www.syndax.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.55% | 1.79B | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- SNDX Stock
- Company Syndax Pharmaceuticals, Inc.